Table 2 Significant multivariate associations between semen outcomes and endocrine measures

Abnormal semen count (< 20 × 10⁶)

Baseline inhibin

0.048

0.98 (0.96–0.99)

0.14

Baseline FSH

0.021

1.69 (1.05–2.8)

0.22

Post Peak GnRH LH

0.015

1.15 (1.03–1.3)

0.24

Post Peak GnRH FSH

0.033

1.4 (1.0–1.9)

0.18

Abnormally low baseline Inhibin (< 100 pg/ml)

0.032

8.2 (1.4–49.2)

0.18

Density

Abnormally low baseline inhibin

-69.5 (32.2)

0.039

0.05

Baseline testosterone

-3.8 (1.83)

0.046

0.04

Baseline inhibin

0.8 (0.3)

0.01

0.25

Abnormal Density (< 40 × 10⁶/ml)

Baseline FSH

0.028

1.85 (1.1–3.2)

0.14

Abnormal morphology (< 2%)

Abnormally high baseline E2 (> 50 pg/ml)

0.013

37.2 (2.1–655.2)

0.18

Abnormal motility (< 50%)

Abnormally high baseline E2

0.046

39.5 (1.1–1450)

0.34

Morphology

Abnormally high baseline E2

-1.27 (0.58)

0.036

0.21